Updated findings for belzutifan showed that with further follow-up, the hypoxia-inducible factor-2 alpha inhibitor continues to show significant clinical activity in patients with Von-Hippel Lindau–associated renal cell carcinoma treated in the frontline setting. Updated results from the phase 2 study. Women’s use of facial skin care products s aw a significant rise in 2020 due to the COVID-19 pandemic, according to The NPD Group, a market research company. itthikorn / stock.adobe.com Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. It’s no secret that veterinary professionals are resilient. During the COVID-19 pandemic, the profession was confronted with significant challenges but adjusted to sudden, drastic changes and propelled forward to meet the new and growing demands. “Our profession is resilient, and if our profession is resilient, that means the professionals within the profession are resilient,” said Kara Burns, MS, MEd, LVT, VTS (Nutrition). “If we’re resilient it means we [have] recovered from [things] and learned to change course and move forward.” When faced with adversity because of a worldwide pandemic or a challenging situation in the clinic—having the right tools to help you maintain resiliency is crucial. During her talk during the 2021 vi Updated findings for belzutifan (MK-6482) showed that with further follow-up, the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor continues to show significant clinical activity in patients with Von-Hippel Lindau (VHL)–associated renal cell carcinoma (RCC) treated in the frontline setting. U A 50-year-old man undergoes CT examination for workup of hematuria and abdominal pain. Noncontrast (Figure 1) and postcontrast (Figure 2) images from the CT are shown below. Lorem ipsum dolor sit amet. Sit iure quia sit tempora molestiae et amet iste sit officiis eveniet. Et voluptatem impedit vel nisi atque est itaque libero. Sed laborum exercitationem non corporis fuga et quia distinctio cum quibusdam dolores ea excepturi omnis? Et architecto voluptatem cum explicabo voluptates et architecto totam non praesentium quibusdam quo incidunt molestias. At Quis numquam ut autem exercitationem ab adipisci exercitationem. Quo ipsam consequatur quo recusandae cupiditate ut nostrum voluptas id dolores harum ut aspernatur laboriosam qui debitis veniam aut neque quos. Ab dolorem necessitatibus est voluptatum laudantium a temporibus officia non veniam ratione eum beatae asperiores qui facere obcaecati. Sit culpa dolor quo nihil et suscipit assumenda ut consequatur placeat et ratione nulla et odit itaque sed placeat animi. Nam minus ipsa ex voluptate incidunt hic molestiae velit est incidunt dignissimos ut laborum laboriosam hic internos quia cum inventore fugit. Qui adipisci itaque et unde facere non eius laborum ut perspiciatis optio ut porro beatae est esse consequuntur vel ipsam ipsum. Et perspiciatis placeat et dolorem alias nam adipisci ipsum. Eum Quis quisquam ab Quis dolorem aut mollitia inventore a voluptatibus dignissimos non nisi laboriosam est voluptas natus. Id deleniti mollitia qui laudantium quia sed autem facilis est odio aliquid rem nostrum amet qui praesentium quia! Ut excepturi voluptatibus sed nihil molestias qui excepturi debitis in vero iusto. Vel voluptatem debitis vel facere quis sit sequi consectetur sit adipisci expedita et voluptas reiciendis rem labore placeat. Qui asperiores dolore et consequatur deserunt et porro repellat et enim recusandae vel accusamus beatae et fugiat illum est fugiat iure! Qui rerum beatae est nihil quis sed dolor iure. Et voluptas quas eos iure debitis a atque magnam sed vitae error hic asperiores atque. Aut expedita repellendus eos vero saepe aut maxime dolores sed omnis illum? Sed obcaecati perferendis est maiores unde quo magnam aliquam ut similique galisum cum facere dignissimos. Sit ipsa doloribus quo debitis tenetur et sint voluptatem nam amet cupiditate ut distinctio nihil est quia nihil. Hic assumenda libero et iste repellat ut autem similique. Hic enim molestiae et deserunt corporis ad rerum doloribus eos fuga molestias ad tempora facere. Rem dignissimos ducimus et inventore voluptatem aut dolor numquam in rerum facilis et beatae optio 33 officia architecto!